Evidence map›Paper›PMID 42438959›Full record

ArticleChemistry, an Asian journal2026

Robust Mixed-Ligand Ni(II)-framework With Pore-Engineered Lewis Acid-Base Sites for Size-selective and One-Pot Mild Synthesis of Bioactive 4H-Pyrans.

Rudra Chand, Bapan Maji, Partha Pratim Mondal, Subhadip Neogi

Abstract read
In one paragraph

Article in Chemistry, an Asian journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Rudra ChandAcademy of Scientific and Innovative Research (AcSIR), Ghaziabad, India.
Bapan MajiAcademy of Scientific and Innovative Research (AcSIR), Ghaziabad, India.
Partha Pratim MondalAcademy of Scientific and Innovative Research (AcSIR), Ghaziabad, India.
Subhadip NeogiAcademy of Scientific and Innovative Research (AcSIR), Ghaziabad, India.ORCID https://orcid.org/0000-0002-3838-4180

Funding

CSIR 31/0028(23891)/2025-EMR-IDST-SERB CRG/2021/002529
6 · The paper itself

Abstract

The rational integration of antagonistic catalytic sites within robust porous architectures remains a critical challenge for sustainable multicomponent reactions to synthesize pharmacologically active molecules. Herein, we report a thermo-chemically stable, mixed-ligand Ni(II)-based pillar-layered metal-organic framework (MOF), featuring activation-induced open metal sites and pore-confined Lewis basic centres. This bifunctional framework acts as an efficient heterogeneous catalyst for one-pot Knoevenagel-Michael multicomponent reactions, enabling the rapid synthesis of structurally diverse 2-amino-3-cyano-4H-pyrans under mild conditions with low catalyst loading. The synthesis of 4H-pyrans is promoted by the synergistic interplay between Lewis acidic metal centres and framework-integrated basic sites, as corroborated by control experiments and analyte-responsive emission modulation. The protocol accommodates twenty-six electronically diverse substrates and affords bioactive pyran derivatives in excellent yields. Notably, the confined pore environment imparts distinct size-selectivity, restricting bulky substrates and demonstrates molecular-dimension-controlled catalysis. The framework exhibits remarkable recyclability, structural robustness, and negligible metal leaching, outperforming many reported catalytic systems. Importantly, eight 4H-pyrans were structurally confirmed in their purest form by single-crystal X-ray diffraction, alongside other spectroscopic characterizations. This work highlights a rational platform for designing bifunctional MOF catalysts to promote green organic synthesis through the synergistic cooperation of antagonistic functionalities confined within porous architectures.

Indexed as

4H‐pyransopen‐metal sitepharmacologically active moleculesize‐selectivitytri‐component reaction

Identifiers

PMID42438959
PMCPMC13358674

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.